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The water channel aquaporin-1 (AQP1) is considered as the
molecular counterpart of the ultrasmall pore predicted by the
three-pore model of fluid transport across the peritoneal
membrane. However, the definitive proof of the implication
of AQP1 in solute-free water transport, sodium sieving, and
ultrafiltration (UF) during peritoneal dialysis (PD) is lacking,
and the effects of its deletion on the structure of the
membrane are unknown. Using real-time reverse
transcriptase-polymerase chain reaction and immunogold
electron microscopy, we showed that AQP1 is the most
abundant member of the AQP gene family expressed in the
mouse peritoneum, and the only one located in the capillary
endothelium. Transport studies during a 2-h dwell
demonstrated that, in comparison with Aqp1þ /þ littermates,
Aqp1/ mice had no sodium sieving; an B70% decrease in
the initial, solute-free UF; and an B50% decrease in
cumulative UF. These modifications occurred despite
unchanged osmotic gradient and transport of small solutes in
the Aqp1/ mice. Heterozygous Aqp1þ / mice showed
intermediate values in sodium sieving and initial UF, whereas
cumulative UF was similar to Aqp1þ /þ mice. The deletion of
AQP1 had no effect on the expression of other AQPs and on
the density, structure, or diameter of peritoneal capillaries.
These data provide direct evidence for the role of AQP1
during PD. They validate essential predictions of the
three-pore model: (i) the ultrasmall pores account for the
sodium sieving, and (ii) they mediate 50% of UF during a
hypertonic dwell.
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The capacity for ultrafiltration (UF) across the peritoneal
membrane is a major predictor of outcome and mortality in
peritoneal dialysis (PD) patients.1,2 Failure of this UF
capacity is the most frequent abnormality in long-term PD
patients, and the main reason for technical failure.3 Fifteen
years ago, B Rippe and co-workers proposed a ‘three-pore’
model based on computer simulations to describe the
exchange of fluid across the peritoneal membrane.4,5 This
model has become an essential tool for PD, as it provides a
comprehensive method for monitoring individual patients
over time and adjusting dialysis prescription.6
The three-pore model predicts that the major transport
barrier of the peritoneum is the capillary endothelium.4–6 The
‘small pores’ (radius 40–50 A˚), which correspond to the clefts
located between endothelial cells, account for B95% of the
hydraulic conductance (UF coefficient, LpS). A second
population of pores, the ‘large pores’ (radius 250 A˚), thought
to correspond to the venular interendothelial gaps, accounts
for 5% of the UF coefficient. These pores are involved in the
transport of macromolecules and, although they represent
only 0.01% of the total number of pores, they mediate an
important part of the UF via convection of plasma from
blood to the peritoneal cavity. The third population of pores
consists in water-specific, ‘ultrasmall pores’ located in the
endothelial cells. The ultrasmall pores account only for 1–2%
of the hydraulic conductance, meaning an almost insigni-
ficant contribution to the overall UF coefficient. However,
because they reject solutes but facilitate the transport of
water, the ultrasmall pores are extremely important during
crystalloid osmosis. Thus, they have been predicted to
mediate half of the UF, as well as the ‘sodium sieving’, that
is, the fall in dialysate sodium concentration, during a dwell
with hypertonic glucose.5,6 Understanding the molecular
counterpart and the role of the ultrasmall pores has a major
clinical importance, since the link between the integrity of the
ultrasmall pores and the UF capacity and sodium sieving
remains a much debated question in PD.7–9
According to the three-pore model, the ultrasmall pore
should be located in the endothelium lining peritoneal
capillaries and postcapillary venules, where occurs most of
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the water movement during PD. It should also facilitate water
movement while being unpermeable to glucose and glycerol,
hence have a minimal radius o3 A˚. The identification of the
aquaporins, a family of integral plasma membrane proteins
found in bacteria, plants, and mammals, provided critical
insights in the molecular mechanisms involved in water
permeation across biological membranes.10 The first identi-
fied member of this family was aquaporin-1 (AQP1), whose
distribution includes red blood cells, renal tubular epithelial
cells, and endothelial cells.11,12
AQP1 is distributed in the endothelium lining capillaries,
venules and small veins of the peritoneum.13,14 The pore
formed by AQP1,15 the inhibition of water permeability by
HgCl2,
16,17 and the reduced osmotically-induced water
transport in mice lacking AQP1 but not in mice lacking
AQP418 supported the hypothesis that AQP1 is the molecular
counterpart of the ultrasmall pore. However, in the absence
of a methodology adequate for transport studies in mouse,
most of the evidence for the role of AQP1 in the peritoneum
thus far was still indirect and/or incomplete. Furthermore,
the expression profile of the AQP gene family, the role of
AQP1 in UF and sodium sieving, the effect of AQP1 deletion
on the transport of small solutes, and the structural
modifications and compensatory mechanisms in the peri-
toneum of AQP1 knockout (KO) mice have not been
investigated.
In this study, we have characterized the expression pattern
of the AQP gene family in the mouse peritoneum and have
used a meticulous infusion model19,20 to provide a direct
evidence of the role of AQP1 in transport across the
peritoneal membrane. Our data validate the predictions of
the three-pore model and give new insights in the regulation
of AQP1 and microvascular permeability.
RESULTS
Clinical and biological parameters of the AQP1 mice
In comparison with wild-type littermates, Aqp1/ mice had
lower body weight, plasma urea, and MAP, whereas
intermediate values were observed in Aqp1þ / mice (Table 1).
As previously described,21 the Aqp1/ mice had an impaired
ability to concentrate urine, as evidenced by polyuria. The
latter was compensated by increased water intake (Aqp1/:
17.771.3 ml/24 h vs Aqp1þ /þ : 6.570.3 ml/24 h, Po0.0001,
N¼ 5 pairs), explaining why plasma sodium levels were
similar in both groups (Table 1). The mice had similar
hematocrit, plasma albumin, and NOx levels in the dialysate
(Aqp1þ /þ : 4373 mM vs Aqp1/: 4674 mM).
Expression patterns of the AQP gene family in the mouse
peritoneum
Real-time RT–PCR analyses (Figure 1) showed that AQP1 was
the most abundant isoform in the visceral peritoneum of
Aqp1þ /þ mice. A significant expression of AQP7 was also
detected, as well as very low levels of AQP9 and AQP5, and
traces of AQP3 (more than 500-fold less than AQP1). The
deletion of AQP1 was not reflected by significant changes in
the expression of the other AQPs in the peritoneum
(Figure 1).
Expression of AQP1 and endothelial markers
The core and glycosylated AQP1 isoforms were identified by
immunoblotting in the visceral peritoneum of Aqp1þ /þ
mice (Figure 2). Of note, AQP1 was apparently less
glycosylated in the peritoneum than in kidney samples,
possibly reflecting the exclusive endothelial expression in the
former tissue. Densitometry analysis confirmed an B50%
reduction in the expression of AQP1 in the peritoneum of
Aqp1þ / mice (in arbitrary units: 32367276 vs 64057192,
respectively, N¼ 4 pairs). The deletion of AQP1 in the
peritoneum was not reflected by significant modifications in
Table 1 | Baseline clinical and biological parameters in the AQP1 mice
Groups N Body weight (g) Plasma sodium (mM) Plasma urea (mg/dl) MAP (mm Hg)
Aqp1/ 6 26.171.0a 15271 1571a 8072a
Aqp1+/+ 6 30.170.8 15172 2171 9573
Aqp1+/ 6 28.970.9 15371 1871 8874
MAP, mean arterial blood pressure; all parameters were obtained before the dwell (T0).
aPo0.05 vs Aqp1+/+.
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Figure 1 | Expression patterns of the AQP gene family in the
mouse peritoneum: semiquantitative and real-time RT-PCR. Left
panel: Representative semiquantitative RT-PCR analysis of the
expression of the AQP gene family in the visceral peritoneum of
Aqp1þ /þ and Aqp1/ mice. Equal amounts (20 ml) of PCR products
were loaded in each lane of a 1.5% agarose gel. Positive control
tissues were from the lens (AQP0); kidney (AQP1, AQP2, AQP3, AQP4,
AQP6); lung (AQP5); adipose tissue (AQP7); liver (AQP8, AQP9); and
small intestine (AQP10). The size of amplicons is given in Table 3.
Right panel: Real-time RT-PCR quantification for mRNA expression of
the AQP gene family members in the mouse peritoneum. The
threshold Ct values (number of cycles needed to generate a signal
above the predefined threshold) were obtained from five different
mice in each group. ND, transcript not detected or Ct431 cycles. The
quantitative difference between two transcripts equals [2DCt].
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the endothelial proteins, endothelial nitric oxide synthase
(eNOS), and caveolin-1, as confirmed by densitometry
analysis (data not shown).
Influence of AQP1 deletion on the structure of the peritoneal
membrane
Morphological examination showed that the deletion of
AQP1 was not reflected by structural changes in the visceral
and parietal peritoneum at baseline (Figure 3a). Morpho-
metry analysis demonstrated that the thickness of the
submesothelial area was similar in both groups (average
thickness: 14.470.7 mm in Aqp1þ /þ mice vs 15.371.4 mm in
Aqp1/ mice; N¼ 7 pairs; see Figure 3a, insets), supporting
the conclusion that the mesothelium and associated con-
nective tissue do not affect the osmotic filtration and small
solutes transport.9
Immunostaining (Figure 3b) showed that AQP1 is
exclusively located in the endothelium lining peritoneal
capillaries and venules of Aqp1þ /þ mice, whereas no specific
staining was detected in the mesothelium. Morphometry
analysis on four pairs of CD31-stained sections confirmed
that the vascular density was not significantly modified by the
deletion of AQP1. No specific staining was detected for
AQP3, AQP5, AQP7, and AQP9 (data not shown).
Immunogold electron microscopy and ultrastructural exam-
ination
Using immunogold EM (Figure 4), we detected a strong
labeling for AQP1 in the endothelial cells lining peritoneal
capillaries (Figure 4a). The labeling for AQP1 was detected
along the plasma membrane and numerous infoldings in
endothelial cells. No staining was detected in the mesothelial
cells. The AQP1 labeling was significantly weaker in
heterozygous mice (Figure 4b) and, as expected, abolished
in the Aqp1/ mice (Figure 4c). The AQP1 labeling was far
stronger in the plasma membranes of endothelial cells than in
red blood cells (Figure 4f), as confirmed by morphometry
(density of AQP1 gold particles in the capillary endothelium,
per mm cell length: 2073.4 in Aqp1þ /þ mice (N¼ 14) vs
9.871.8 in Aqp1þ / mice (N¼ 9) vs 2.270.2 in the red
blood cell of Aqp1þ /þ mice (N¼ 10); Po0.05 for all
comparisons). No labeling for AQP3 (nor AQP7 and AQP9)
was detected in red blood cells, endothelial cells, and
mesothelial cells, either in Aqp1þ /þ (Figure 4g and h) or
Aqp1/ mice (Figure 4i and j).
The ultrastructure of capillary endothelial cells (Karnovski
staining) was similar in Aqp1þ /þ (Figure 4d) and Aqp1/
(Figure 4e) mice. The endothelial cells exhibited numerous
caveolae and plasma membrane infoldings, and neither the
thickness of the cells nor the diameter of capillaries was
significantly modified (internal capillary diameter in mm:
2.970.2 in Aqp1þ /þ mice (N¼ 11) vs 2.970.4 in Aqp1/
mice (N¼ 9)).
Role of AQP1 in UF and small solute transport during PD
We used a PET adapted for the mouse19,20 to investigate the
effects of AQP1 deletion on transport across the peritoneum
(Table 2; Figure 5). In Aqp1þ /þ mice, exposure to the
dialysate induced a typical sodium sieving (Figure 5a), a
progressive reabsorption of glucose from the dialysate (Figure
5b), and a net UF (Table 2). The Aqp1/ mice showed a
complete loss of sodium sieving and an B50% decrease in
net UF, whereas glucose reabsorption from dialysate and D/P
osmolality at 30 min were unchanged. In comparison with
wild-type mice, Aqp1þ / mice showed anB25% decrease in
sodium sieving (P¼ 0.06), whereas the net UF values
obtained at the end of the 2-h dwell were similar. Of note,
small solute transport parameters (evaluated by mass transfer
area coefficient of urea and D120/D0 glucose) were similar in
the three groups of AQP1 mice. The qualitative differences in
peritoneal transport parameters were verified in different
groups of mice, irrespective of gender, inflow volume (2.0 vs
2.5 ml) and glucose concentration (7% vs 3.86%) in the
dialysate (data not shown).
The intraperitoneal volume curves were assessed using a
125I-human serum albumin dilution technique.22 The total
125I-human serum albumin masses retrieved from the
peritoneal cavity after 30 s were similar in all genotypes
(9672% in Aqp1þ /þ , 9773% in Aqp1/, and 9671 % in
Aqp1þ /, N¼ 3 in each group), as were the total protein loss
in the dialysate at the end of the dwell (3.870.3 mg in
Aqp1þ /þ , 3.870.2 mg in Aqp1/, and 4.370.3 mg in
Aqp1þ /, N¼ 6 in each group). The average curves (Figure
5c) obtained in the Aqp1/ mice were significantly lower
than in the Aqp1þ /þ and Aqp1þ / mice. The initial UF rates
were clearly distinct: 33.571.8 ml/min for Aqp1þ /þ ,
22.271.3 ml/min for Aqp1þ /, and 10.170.6 ml/min for
Aqp1/ mice (Figure 5d). The volume curves were closely
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Figure 2 | Expression of AQP1 and endothelial markers: immu-
noblotting. Representative immunoblots for AQP1 (1:20 000) in
kidney and peritoneum extracts prepared from Aqp1þ /þ , Aqp1þ /
and Aqp1/ mice (20 mg protein/lane). The blots were stripped and
reprobed with a monoclonal antibody against b-actin (1:10 000) for
loading accuracy. The core (28 kDa) and glycosylated (35–50 kDa)
AQP1 isoforms are identified in the kidney and peritoneum of
Aqp1þ /þ mice, whereas an intermediate signal is observed in
heterozygotes and no signal is detected in the Aqp1/ mice. Note
the lower abundance of glycosylated AQP1 isoforms in peritoneum vs
kidney samples. The expression of eNOS (1:5000) and caveolin-1
(1:2500) was also tested in the same peritoneal samples and showed
no significant difference.
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similar, at least during 0–60 min, to those computer
simulated by the three-pore model of peritoneal transport
by rescaling all relevant exchange parameters by BW0.7 (using
a scaling factor of 230 from man to mouse) (data not shown).
The initial UF rate significantly correlated with the sodium
sieving obtained in the same mice (regression:
y¼ 2.563þ 0.21x, r¼ 0.71, P¼ 0.001).
DISCUSSION
A prerequisite of the three-pore model is the existence of
ultrasmall pores in the endothelium lining peritoneal
capillaries.5 These pores are predicted to be responsible for
the sodium sieving and up to 50% of the UF during a
hypertonic dwell.5,6 Our data provide a direct demonstration
that AQP1 mediates the initial, solute-free water transport
(assessed clinically by the sodium sieving) as well as half of
the UF during PD in mouse. The modifications observed in
Aqp1/ mice occur without changes in the osmotic gradient,
and without affecting the microvascular structure and density
in the peritoneal membrane.
Previous studies in Aqp1/ mice have shown that AQP1
plays a role in osmotically driven water permeability in
microvessels lining distal airways23 and in the descending
vasa recta.24 In contrast, the deletion of AQP1 in the
endothelium of salivary glands has no effect on salivary fluid
production.25 A preliminary study showed that AQP1 is
involved in the osmotically induced water transport across
the peritoneal membrane.18 However, that study did not
address the contribution of AQP1 in the sodium sieving and
UF, the possibility of compensatory mechanisms, and the
situation in heterozygous mice. The present study addressed
these questions, using a well-characterized infusion model on
the AQP1 mouse.19,20
The functional loss of AQP1 is traditionally considered as
a potential cause of a loss of sodium sieving.26 This
hypothesis, however, has been challenged by the apparently
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Figure 3 | Structure and vascular density of the peritoneal membrane. (a) Hemalun–eosine staining in the parietal (upper panels) and
visceral peritoneum (lower panels) of Aqp1þ /þ and Aqp1/ mice shows that the deletion of AQP1 is not reflected by structural changes of the
peritoneal membrane. Insets: representative sections of the submesothelial area in the parietal peritoneum (Sirius red staining) at higher
magnification, showing a similar thickness in both groups. (b) The immunoreactivity for AQP1 (1:200; upper panels) is located in the
endothelium lining peritoneal capillaries and venules in Aqp1þ /þ mice, whereas no staining is detected in the mesothelium. As expected, there
was no labeling in Aqp1/ mice. The density of capillaries and blood vessels stained for the endothelial marker CD31 (1:50; lower panels) is
similar in Aqp1þ /þ and Aqp1/ mice. The morphometry analysis in the visceral peritoneum (CD31 staining) confirmed that the vascular
density (in vessels/mm2: 9376 in Aqp1þ /þ mice vs 83725 in Aqp1/ mice) (right panel) is not modified by the deletion of AQP1.
Bar¼ 100 mm; m, mesothelium; the genotype is indicated in the upper left corner.
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intact expression of AQP1 in such patients.27,28 Similarly, the
link between UF failure and integrity of AQP1 remains
debated.6,8,9,28 The present study provides a direct answer, by
showing that the deletion of AQP1 induces a loss of sodium
sieving, with a close relationship between the level of AQP1
expression and the initial, solute-free UF rate (Figure 5).
Also, these results provide a mirror image of previous data
showing that pharmacological induction of AQP1 expression
is reflected by an increased sodium sieving.29 The residual
initial UF rate in the Aqp1/ mice suggests that a non-AQP1
pathway participates in the initial osmotic water flux across
the endothelium – similar to what has been postulated in the
descending vasa recta.24 The identity of this alternative water
pathway remains to be defined. The lack of variation of the
submesothelial area thickness confirms that the mesothelium
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Figure 4 | Immunogold electron microscopy and ultrastructural
examination of the endothelium in the peritoneum of Aqp1þ /þ
and Aqp1/ mice. (a–c) Immunogold labeling on mouse visceral
peritoneum revealed a very strong signal for AQP1 in plasma
membranes and plasma membrane infoldings of capillary endothelial
cells in (a) Aqp1þ /þ mice. (b) The AQP1 labeling was markedly
weaker in heterozygous mice, but remained easily detectable. No
labeling was detected in (c) Aqp1/ mice, demonstrating the
specificity of labeling with this antibody. (f) Comparison of the
labeling density in wild-type mice shows that AQP1 labeling is
markedly stronger in endothelial cells than in red blood cells. No
AQP1 labeling was detected in mesothelial cells. (d, e) Karnovski
staining of epon sections of mouse parietal peritoneum shows that
capillary endothelial cells exhibit numerous caveolae and plasma
membrane infoldings both in (d) Aqp1þ /þ and (e) Aqp1/ mice. No
difference in the ultrastructure of capillaries or veinules was detected
between genotypes. (g–j) No labeling for AQP3 was detected in red
blood cells, endothelial cells and mesothelial cells, either in (g, h)
Aqp1þ /þ or (i, j) Aqp1/ mice. Bars¼ 500 nm; e, endothelium; m,
mesothelium; rc, red blood cell; l, capillary lumen. The AQP1
genotype is indicated in the upper right corner.
Table 2 | Water and small solute transport in the AQP1 mice
Groups N Net UF/BW (ll/g) P30 sodium (mM) D30 sodium (mM) Sodium sieving (%) D30/P30 osmolality MTAC urea
a (ll/min)
Aqp1/ 6 2771.8b,c 14671 13771b,c 6.571.0b,c 1.3470.09 3371.0
Aqp1+/+ 6 5873.1 14772 12372 6.071.3 1.2870.03 2872.5
Aqp1+/ 6 5772.0 14871 12671 3.170.9 1.2670.02 2974.0
BW, body weight; D30, dialysate concentration at 30 min; P30, plasma concentration at 30 min; sodium sieving=(D0/P0–D30/P30)/D0/P0 100 (in %); UF, ultrafiltration;
aMTAC, mass transfer area coefficient ((ml/min) of urea, according to the Garred two-sample model.20
bPo0.05 vs Aqp1+/+.
cPo0.05 vs Aqp1+/.
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Figure 5 | Effect of AQP1 deletion on water and solute transport
parameters. (a) The dialysate-to-plasma (D/P) ratio of sodium, (b) the
progressive removal of glucose from the dialysate (D/D0 glucose,
(c) the volume vs time [V(t)] curves, and (d) the initial UF rates
calculated from the first derivate of the best fitting curves for each
mouse were determined in Aqp1þ /þ mice (black squares), Aqp1þ /
mice (black triangles), and Aqp1/ mice (black circles) during a 2-h
exchange with 2 ml of 7% glucose dialysate. In comparison with
Aqp1þ /þ mice, mice lacking AQP1 show a complete loss of sodium
sieving, whereas the glucose reabsorption from dialysate is un-
changed. Aqp1/ mice also show significantly lower volume curves
and initial UF rates. Intermediate values of sodium sieving and initial
UF rates are observed in Aqp1þ / mice. *Po0.05 vs Aqp1þ /þ mice
and #Po 0.05 vs Aqp1þ / mice.
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and associated connective tissue do not affect the osmotic
filtration.9
Our data validate a second prediction of the three-pore
model, that is, that AQP1 mediates B50% of the net UF
during a hypertonic dwell,5,6 without affecting the small
solute transport rate. Although apparently surprising, the fact
that the cumulative UF is not decreased in the heterozygous
Aqp1þ / mice was also predicted by the three-pore model.
Indeed, changes in the initial water transport must
be dissociated from the cumulative UF after a long dwell (a
2 h-dwell in mouse corresponds to a 6–8 h-dwell in man).5,6
The cumulative UF depends from different variables,
including availability of the small pores and a sustained
osmotic gradient. Accordingly, a reduction in the UF
coefficient accounted for by aquaporins (i.e. the situation
of the Aqp1þ / mice) will not affect the cumulative UF after
a long dwell: the simulated volume curves corresponding to
control or reduced aquaporins eventually converge over time,
resulting in similar UF.30 These data may have an important
clinical implication, since they suggest that the water
transport mediated by AQP1 is particularly important in
short dwells, for instance those performed in automated PD.
AQP1 is the most abundant AQP transcript in the mouse
peritoneum, and the sole isoform detected in the endothe-
lium lining peritoneal capillaries and post-capillary venules,
the principal location for fluid exchange in PD.31 Immuno-
gold EM studies revealed that AQP1 expression is B10-fold
stronger in the plasma membrane of endothelial cells than
red blood cells. On the basis of such expression levels, one
could expect that the deletion of AQP1 may lead to
adaptative changes in the microvasculature. For instance,
the descending vasa recta in the medulla of Aqp1/ mice are
remarkably larger in diameter, which could participate in
increasing the medullary blood flow.24 Yet, the deletion of
AQP1 is not reflected by changes in the density, structure,
or diameter of peritoneal capillaries. This observation is
actually not surprising when considering that the perme-
ability of the peritoneum is only challenged during PD,
that is, when an osmotic agent is instilled in the peritoneal
cavity. In contrast, the vasa recta are constantly exposed
to large osmotic gradients in the kidney medulla. In
agreement with our previous studies,19 the lack of modifica-
tion of the small solute transport in the Aqp1/ mice
probably reflects the lack of modification in microvascular
density and the stability of eNOS expression and NOx levels
in these mice.
As described in the original colony,21 mice lacking
AQP1 show a 15% drop in blood pressure (MAP). Studies
in PD patients showed that a B20% lowering of blood
pressure with ACE inhibitors has no significant effect in drain
volume and glucose absorption during PD.32 Studies in rat
models showed that even large (up to 60%) blood flow
reduction has no significant effect on the osmotic water
flow across the peritoneum.33 In control mice,20 as well as in
the Aqp1þ /þ mice used here, an experimental decrease in
MAP had no effect on UF. The lack of effect of blood pressure
changes on transport parameters is probably explained
by the fact that the endothelium is in series with the
interstitium, which blunts the effect of blood pressure
lowering on UF.9
The putative role of aquaporins other than AQP1 in the
peritoneum has also been debated. The real-time RT-PCR
analysis confirms that AQP1 is the most abundant transcript
in mouse peritoneum, whereas the non-endothelial AQP7
(adipose tissue), AQP9 (leukocytes), and AQP3/AQP5
(macrophages, dendritic cells) were detected with much
lower intensity. Using immunogold EM, we showed that
AQP1 is exclusively located in the endothelium and is not
detected in mesothelial cells. These results, which confirm
previous studies in mouse19,20 and rat,29 contrast with the
inconsistent staining for AQP1 observed in rat and human
mesothelium.14,34,35 The discrepancy could be explained by
the state of cell differentiation, or the osmo-induction of
AQP1 in mesothelial cells.35,36 Because the mesothelium does
not represent a significant functional barrier for water
transport in PD, the importance of AQP1 at that level
is unclear. A similar conclusion can be drawn regarding
the putative role of aquaglyceroporins (AQP3/AQP7/AQP9)
in the peritoneum. The nonendothelial distribution of
these isoforms and the fact that glycerol is an effective
osmotic agent argue against their functional role in transport
during PD.
In conclusion, the data presented here validate essential
predictions of the three-pore theory and provide a direct
demonstration of the critical role played by AQP1 in the
sodium sieving and UF during PD. They also give novel
insights in the molecular mechanisms operating in the
peritoneal membrane and the capillary endothelium in
general.
MATERIALS AND METHODS
Animals
Mice lacking AQP1 were generated as previously described.21 We
used gender-matched littermates, aged 8–12 weeks. All animals had
access to standard diet and tap water ad libitum. The experiments
were conducted in accordance with the National Research Council
Guide for the Care and Use of Laboratory Animals and the local
Ethics Committee.
Peritoneal transport studies and tissue sampling
Transport across the mouse peritoneum was investigated using a
modified PET with 7% glucose-based dialysate (2.0 ml; DianealR,
Baxter, Nivelles, Belgium) as described previously.19,20 Blood and
dialysate samples were taken at time 0, 30, 60, and 120 min of the
dwell. Net UF was measured at the end of the dwell. The transport of
small solutes was evaluated by the mass transfer area coefficient of
urea, according to the Garred two-sample model,20 and the D120/D0
glucose. Other parameters were assayed as described.20 The level of
nitrite and nitrate (NOx) was measured using the Griess reaction
(Cayman Chemical, Ann Arbor, MI, USA).
To obtain volume curves and initial UF rates, the peritoneal
cavity was infused with 2.5 ml of 3.86% glucose dialysate containing
50 ml of 10% bovine serum albumin and 50 ml of 125I-human serum
albumin. Dialysate and blood samples (10ml) were counted in a
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g-counter (Canberra, Meriden, CT, USA). Intraperitoneal volume as
a function of dwell time [V(t)] was assessed as described
previously.22 Preliminary experiments verified that the rapid
peritoneal adsorption of 125I-human serum albumin was similar in
all groups of mice. The initial UF rates were calculated according to
Stelin and Rippe.4 The best fitting volume curve was calculated
using nonlinear least-squares regression analysis. At the end of the
dwell, mice were killed by exsanguination and samples were
processed for fixation (parietal and visceral peritoneum) and
mRNA/protein extraction (visceral peritoneum).
RT-PCR and semiquantitative real-time RT-PCR
Total RNA from mouse visceral peritoneum was extracted with
Trizol (Invitrogen, Merelbeke, Belgium), treated with DNase I and
reverse-transcribed into cDNA. The primers are given in Table 3.
Changes in target genes mRNA levels were determined by
semiquantitative real-time RT-PCR with an iCycler IQ System
(Bio-Rad Laboratories, Hercules, CA, USA) using SYBR Green I
detection as described.20 All reactions were performed in duplicate.
The PCR conditions were 941C for 3 min followed by 31 cycles of
30 s at 951C, 30 s at 611C and 1 min at 721C. To exclude
amplification from contaminating genomic DNA, samples of RNA
that had not been reverse-transcribed were run in parallel PCR
reaction. Standards curves were prepared by serial four-fold
dilutions of cDNA samples for each assay. The efficiency of the
reactions was calculated from the slope of the standard curve
[efficiency¼ (101/slope)1].
Antibodies
We used a rabbit antibody against AQP1 (Chemicom International,
Temecula, CA, USA); a monoclonal antibody against eNOS
(Transduction laboratories, Lexington, KY, USA); a goat antibody
against CD31 (Santa Cruz Biotechnology, Santa Cruz, CA, USA);
polyclonal antibodies against AQP3,37 AQP5,38 AQP7 and AQP9
(Chemicon, Temecula, CA, USA); a rabbit antibody against
caveolin-1 (BD Biosciences, Erembodegem, Belgium); and a
monoclonal antibody against b-actin (Sigma, St Louis, MO, USA).
Immunoblotting
SDS-PAGE and immunoblotting were performed as described.19,20
The membranes were blocked for 30 min, incubated overnight with
the primary antibody at 41C, washed, incubated for 1 h with
secondary antibodies (Dako, Glostrup, Denmark), and visualized
with enhanced chemiluminescence (Amersham, Little Chalfont,
UK). Densitometry analysis was performed using the NIH-Image
V1-57 software.20,21
Tissue staining and immunohistochemistry; quantification of
vascular density
Samples from the visceral and parietal peritoneum were fixed in 4%
paraformaldehyde and embedded in paraffin. Staining (hemalun–
eosine and Sirius red) and immunostaining were performed as
previously described.19,34 Sections were viewed under a Leica DMR
coupled to a Leida DC 300 camera (Leica, Heerbrugg, Switzerland).
Microvascular density was assessed using CD31 immunostaining.39
Sections were digitalized to measure the vascular density (in N
vessels/mm2),19 in four pairs of mice (mean of 10 fields per sample).
A similar method was used to measure the thickness of the
submesothelial area of the parietal peritoneum (Sirius red staining)
in seven pairs of mice.
Transmission electron microscopy
Mouse peritoneum was processed for ultrastructural studies and
immunogold labelling as previously reported.20,29 Samples were
fixed in 4% parafomaldehyde and embedded either in Unicryl (gold
labeling) or in epon (Karnovski staining). For Karnovski staining,
sections were counterstained in 0.2% lead citrate for 1 min. For gold
labeling, the sections were incubated with the primary antibody
(3mg/ml final dilution) and, after washing, with a 1:20 dilution of
10 nm of gold-conjugated anti-rabbit antibodies (Amersham),
before washing and staining in 5% uranyl acetate followed by lead
citrate. The sections were observed on a Philips EM 400 microscope
(Fei, Netherlands).
Data analysis
Data are mean7s.e.m. Comparisons were performed using one-way
ANOVA, followed by Bonferroni’s multiple comparison test.
Significance level was Po0.05.
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Table 3 | Sequences of primers and efficiency of RT-PCR
reactions
Gene Sequence of primers
Amplicons
(bp) Efficiencya
GAPDH Sense TGCACCACCAACTGCTTAGC 176 1.0470.03
Antisense GGATGCAGGGATGATGTTCT
AQP0 Sense TTCTGGCCTTTACCCTGCTT 150 0.9970.04
Antisense TCCCACCAGACCTCCTAAC
AQP1 Sense GCTGTCATGTACATCATCGCCCAG 107 1.0370.04
Antisense AGGTCATTGCGGCCAAGTGAAT
AQP2 Sense TCACTGGGTCTTCTGGATCG 147 1.0370.04
Antisense CGTTCCTCCCAGTCAGTGT
AQP3 Sense GGGCTTCAATTCTGGCTATG 153 1.0070.01
Antisense GAAGACACCAGCGATGGAAC
AQP4 Sense TGTGCACACGAAAGATCAGC 144 1.0370.02
Antisense TTCCATGAACCGTGGTGACT
AQP5 Sense TGGAGCAGGCATCCTGTACT 151 0.9870.01
Antisense CGTGGAGGAGAAGATGCAGA
AQP6 Sense GGTCCACAACAGCACATCAA 143 1.0270.06
Antisense GTGCCACAGAGGTTCCAATC
AQP7 Sense CCTGAGTGCTGGGGATACA 146 1.0470.02
Antisense AGACATTCCCCCTTGACACC
AQP8 Sense ATGGCTGGCTACTGGGACTT 145 1.0170.01
Antisense CGCCAGCAGTTCTTCTTCAC
AQP9 Sense TATCCCCAGAAGCCCAAACT 145 0.9370.01
Antisense GCTGTTGGGATCAAACTGGA
AQP10 Sense GGGGTTGCTTCCTAAGTGCT 151 0.9370.01
Antisense GACAAAGGGAGGGGTCAGA
aThe efficiency of the reactions was calculated from the slope of the standard curve
[efficiency=(101/slope)–1].
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